Watchlist Price Alert

Pacific Biosciences of Ca... (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.10

-0.05 (-4.35%)

At close: May 14, 2025, 3:59 PM

1.11

0.43%

After-hours: May 14, 2025, 07:59 PM EDT

-4.35% (1D)

Bid	1.09
Market Cap	331.59M
Revenue (ttm)	152.36M
Net Income (ttm)	-657.75M
EPS (ttm)	-2.74
PE Ratio (ttm)	-0.4
Forward PE	-1.8
Analyst	Buy

Ask	1.14
Volume	6,695,713
Avg. Volume (20D)	9,178,001
Open	1.15
Previous Close	1.15
Day's Range	1.10 - 1.15
52-Week Range	1.06 - 2.72
Beta	2.19

About PACB

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PACB

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PACB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Pacific Biosciences of California has released their quartely earnings on May 8, 2025:

Revenue of $37.15M exceeds estimates by $253K, with -4.27% YoY decline.

EPS of -0.15 exceeds estimates by 0.04, with 42.31% YoY growth.

Why Price Moved

5 days ago

-6.67%

Pacific Biosciences shares are trading lower. The ... Unlock content with Pro Subscription

1 month ago

+20.83%

Pacific Biosciences of California shares are trading higher after the company reported its Q1 prelimary revenue results.

News

2 days ago · zacks.com

PACB Stock May Rise Following the Deal With Chulalongkorn University

PacBio and Chulalongkorn University launch Asia Pacific's first population-scale HiFi WGS newborn screening program, advancing precision medicine in Thailand.

6 days ago · zacks.com

PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates

Despite strong Service and other revenues, PACB reports soft first-quarter 2025 results partly due to lower Revio system shipments.

5 days ago · zacks.com

Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metri...

6 days ago · seekingalpha.com

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Todd Friedman - Senior Director, Finance & Investor Relations Christ...

6 days ago · zacks.com

Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year ago.

2 weeks ago · zacks.com

Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.11, marking a -1.77% move from the previous day.

3 weeks ago · zacks.com

Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.17, marking no change from the previous day.

1 month ago · marketwatch.com

Pacific Biosciences Names Jim Gibson Chief Financial Officer

Pacific Biosciences of California has hired Jim Gibson as its new chief financial officer, effective March 31.

1 month ago · zacks.com

Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors

Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.

1 month ago · zacks.com

Here's Why You Should Retain PacBio Stock in Your Portfolio Now

PACB continues to deliver growth from its unique technologies amid macroeconomic concerns.

Load More News